Highlights of the 2018/2019 business year

WeissBioTech sets up new production facility in Büttelborn

BRAIN subsidiary WeissBioTech (WBT) set up a new production facility in Büttelborn during 2019. This facility will be used to develop and produce enzymes, yeasts and processing agents to manufacture fruit and vegetable juices, wine and beer, and to produce bioethanol. The laboratories in Büttelborn have been specially designed for application-based work. The geographical proximity to BRAIN AG and other key partners is advantageous as research and development continues to be conducted mainly at BRAIN AG in Zwingenberg. The new production site was designed in accordance with the latest ISO and food safety standards such as ISO-22000 and the FSSC system. Its size of 4,500-square-meters means a significant expansion of WBT’s storage, production and research facilities. The company continues to maintain an administrative unit in Ascheberg near Münster, but is relinquishing its Chanteloup-en-Brie site near Paris. The inaugration of the new facility took place in December 2019.

Biocatalysts expands and optimizes production capacity

Construction of the new production plant at BRAIN subsidiary Biocatalysts has also progressed significantly in 2019. The facility will contain leading edge technology delivering LEAN manufacturing methodology. This sixteen fold increase in Biocatalysts fermentation capacity will give seamless scale up capability from bench top to full commercial manufacturing. The facility will safeguard customer supply and enable delivery of the company growth strategy. Commissioning, site hand-over, celebratory opening events and ultimately routine manufacturing are scheduled for the near future.

Production plant Biocatalysts
© Biocatalysts
BRAIN Moving Mitosis copyright Helga Griffiths
© for photographs of the work: Luise Böttcher, BRAIN AG; Courtesy of Helga Griffiths

100 years of Bauhaus and the Bergstrasse

BRAIN is taking the opportunity of the 2019 Bauhaus anniversary to showcase its architectural heritage. In cooperation with the town of Zwingenberg and the Savings Bank Cultural Foundation of Hesse-Thuringia, the company was the centre of cultural events in fall 2019.

SolasCure Wordmarque

BRAIN spin-off Solascure selected for the Urgo Mentorship Program

With its Mentorship Program, URGO, a French healthcare group, addresses start-ups in the medical technology sector seaking the support of a global industrial partner. This year BRAIN’s spin-off SolasCure, which has developed an innovative biological wound care solution, was selected for the Mentorship Program. As a consequence, SolasCure will benefit for one year from tailored advice from URGO Group experts, helping develop its innovation in areas such as marketing, business models, clinical trials, intellectual property and market access.

BRAIN AG reports strong nine-month figures showing growth in all areas

BRAIN AG sells its entire interest in Monteil Cosmetics International GmbH

BRAIN group attending IFT19 for the first time – Expansion of business activities in the US market

BRAIN Group companies BRAIN AG, Biocatalysts Ltd and AnalytiCon Discovery were represented at a joint stand at this year‘s Annual Meeting & Food Expo of the Institute of Food Technologists (IFT) in June 2019. As BRAIN Group companies, they joined forces to offer a unique customer-focused combination of resources and technologies to deliver value added to the food industry. Activities at the IFT19 generated many valuable business contacts. Presence at this tradeshow aims to strengthen the expansion of BRAIN’s business activities in the US market.

BRAIN AG achieves significant growth in the first half of the 2018/19 financial year

Biocatalysts Win Prestigious Queen’s Award for Enterprise

Biocatalysts Ltd has been named one of the best businesses in the country, winning the Queen’s Award for Enterprise in Innovation. This prestigious award has been made in recognition of Biocatalysts’ drive and approach in providing the best enzyme solutions to their customers.

Raw material sources of the future – Minister of Economic Affairs Tarek Al-Wazir visits BRAIN

At a forum held at BRAIN by Hessen Trade & Invest GmbH on the subject of “Raw Material Sources of the Future”, Hesse’s Minister of Economic Affairs Tarek Al-Wazir acknowledged BRAIN as a bioeconomy pioneer and presented a the official notification of a grant for a project to recover valuable metals from waste streams.

Global beverage company has joined the DOLCE program

BRAIN Annual General Meeting 2019
© Archiv BRAIN AG

Annual General Meeting of BRAIN AG resolves all agenda items with broad majorities

View press release

BRAIN AG starts the 2018/19 financial year with a strong first quarter

Biocatalysts Evolution
© Biocatalysts

The Evolution of Biocatalysts Ltd.

After 25 years as Managing Director of Biocatalysts Ltd, Stuart West is handing over this position to Rod Sears-Black and taking up a role as Non-Executive Director. Stuart’s drive and commitment to the business has seen the company grow into a world-renowned speciality enzyme solution provider.

Read the news

BRAIN achieves double-digit growth in total operating performance and revenues in the 2017/18 financial year

Jürgen Eck elected most innovative CEO of the biotech industry

Readers of the bioeconomics blog „Il Bioeconomista“ voted BRAIN’s CEO Jürgen Eck the most innovative CEO of the biotech industry.

Global beverage company joins BRAIN’s newly established FRESCO program for nature-based preservation ingredients

Manfred Bender set to join the Management Board of BRAIN AG as Chief Financial Officer (CFO)

In his role as Chief Financial Officer, Manfred Bender will drive forward BRAIN’s growth-oriented strategy. A key facet of his job will be the continued focus on M&A activities in order to expand global B2B market access.

Suntory Beverage & Food Europe and BRAIN AG start Joint Development Program

Ludger Roedder to join BRAIN AG Management Board

In the newly created position of Chief Business Officer (CBO), Ludger Roedder will assume responsibility for further expanding the BRAIN Group’s product business and steer the continuous evolution of BRAIN’s product portfolio and client-specific product development programs.

Biocatalysts Ltd Win Made in Wales Award for Sustainability

Biocatalysts Ltd is proud to announce that the company has won the Sustainable/Ethical Manufacturer award at the recent Made in Wales Awards. This follows the great achievement of becoming a zero waste to landfill manufacturing company in June 2018.

Read the news

Scientists of BRAIN AG receive top award for developing novel bioactive antiperspirants for cosmetics and skin care

A senior researcher of BRAIN has received the top award in the Applied Research category at the 30th IFSCC Congress. The research team at BRAIN, together with scientific partners, has developed a new concept for sweat reduction based on directly targeting primary fluid secretion in human sweat glands. This work offers a novel approach addressing growing demand for natural-source and aluminium-free antiperspirants and deodorants.

Enzymestructur of Aurase designed for BRAIN Annual Report Cover 2018-19

To BRAIN Annual Report 2018/19

BRAIN Annual Report 2018/19 with the title ”Pioneering Bioproducts”

Annual Report 2018/19

Share this page